Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder
João P. De Aquino, Suprit Parida, Mehmet Sofuoglu
Clinical Drug Investigation (2021) Vol. 41, Iss. 5, pp. 425-436
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Outpatient Low-Dose Initiation of Buprenorphine for People Using Fentanyl
Leslie W. Suen, Amy Yunyu Chiang, Benjamin L. Jones, et al.
JAMA Network Open (2025) Vol. 8, Iss. 1, pp. e2456253-e2456253
Open Access | Times Cited: 2
Management of Xylazine Withdrawal in a Hospitalized Patient: A Case Report
Rachel Ehrman-Dupre, Caroline Kaigh, Matt Salzman, et al.
Journal of Addiction Medicine (2022) Vol. 16, Iss. 5, pp. 595-598
Closed Access | Times Cited: 57
Withdrawal during outpatient low dose buprenorphine initiation in people who use fentanyl: a retrospective cohort study
Benjamin L. Jones, Michelle Geier, John Neuhaus, et al.
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 6
Illicit Fentanyl Use and Hepatitis C Virus Seroconversion Among People Who Inject Drugs in Tijuana and San Diego: Results From a Binational Cohort Study
Joseph Friedman, Daniela Abramovitz, Britt Skaathun, et al.
Clinical Infectious Diseases (2024) Vol. 79, Iss. 4, pp. 1109-1116
Closed Access | Times Cited: 6
Novel Uses of Methadone Under the “72-Hour Rule” to Facilitate Transitions of Care and Low-Dose Buprenorphine Induction in an Outpatient Bridge Clinic
Minaliza Shahlapour, Sabetta Singh, Paul J. Christine, et al.
Journal of Addiction Medicine (2024) Vol. 18, Iss. 3, pp. 345-347
Closed Access | Times Cited: 5
Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: an updated systematic review
Kathleen K. Adams, Kristin Waters, Diana M Sobieraj
Addiction Science & Clinical Practice (2025) Vol. 20, Iss. 1
Open Access
Lessons from the National institutes of health innovation corps program: defining barriers to developing and commercializing novel solutions for persons with opioid use disorder
Matthew Heshmatipour, Tyler M. Duvernay, Desislava Z. Hite, et al.
Addiction Science & Clinical Practice (2025) Vol. 20, Iss. 1
Open Access
Low Dose Initiation of Buprenorphine: A Narrative Review and Practical Approach
Shawn M. Cohen, Melissa B. Weimer, Ximena A. Levander, et al.
Journal of Addiction Medicine (2021) Vol. 16, Iss. 4, pp. 399-406
Closed Access | Times Cited: 37
Buprenorphine precipitated opioid withdrawal: Prevention and management in the ED setting
Anthony Spadaro, Brit Long, Alex Koyfman, et al.
The American Journal of Emergency Medicine (2022) Vol. 58, pp. 22-26
Open Access | Times Cited: 23
Buprenorphine: New Challenges and Opportunities
Sabrina Corrêa da Costa, Mohammad Ghafouri, Lantie Jorandby, et al.
Current Addiction Reports (2025) Vol. 12, Iss. 1
Closed Access
Buprenorphine Microdosing the “Bernese Method”: Patient Selection in Opioid Treatment
L. A. Hanrahan
The Journal for Nurse Practitioners (2025) Vol. 21, Iss. 2, pp. 105300-105300
Open Access
Buprenorphine Pharmacodynamics: A Bridge to Understanding Buprenorphine Clinical Benefits
Mellar P. Davis
Drugs (2025)
Closed Access
Retrospective Observational Descriptive Study on Use and Rotations to Belbuca ®
Marzia Barbieri, Neil Shah, Julia Iskra, et al.
Journal of Pain & Palliative Care Pharmacotherapy (2025), pp. 1-15
Closed Access
Barriers to Buprenorphine Treatment Among People Experiencing Homelessness: A Qualitative Study from the Provider Perspective
Carmen L. Masson, Kelly R. Knight, Eugene Levine, et al.
Journal of Urban Health (2025)
Open Access
Synergistic Effect of Ketamine and Buprenorphine Observed in the Treatment of Buprenorphine Precipitated Opioid Withdrawal in a Patient With Fentanyl Use
Christian Hailozian, Josh Luftig, Amy Liang, et al.
Journal of Addiction Medicine (2021) Vol. 16, Iss. 4, pp. 483-487
Closed Access | Times Cited: 29
Precipitated Opioid Withdrawal Treated With Ketamine in a Hospitalized Patient: A Case Report
Nicholaus J. Christian, Jenna L. Butner, Mariah S. Evarts, et al.
Journal of Addiction Medicine (2023) Vol. 17, Iss. 4, pp. 488-490
Closed Access | Times Cited: 10
Illicit Fentanyl Use Independently Predicts HCV Seroconversion Among a Cohort of People Who Inject Drugs in Tijuana and San Diego
Joseph Friedman, Daniela Abramovitz, Britt Skaathun, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Top Ten Tips Palliative Care Clinicians Should Know About Buprenorphine
Kyle Neale, Melissa B. Weimer, Mellar P. Davis, et al.
Journal of Palliative Medicine (2022) Vol. 26, Iss. 1, pp. 120-130
Closed Access | Times Cited: 16
Overview of best practices for buprenorphine initiation in the emergency department
Terence M. Hughes, Nicholas Nasser, Avir Mitra
International Journal of Emergency Medicine (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 3
Buprenorphine Microdosing for the Pain and Palliative Care Clinician
Kyle Quirk, Maximillian H. Stevenson
Journal of Palliative Medicine (2022) Vol. 25, Iss. 1, pp. 145-154
Closed Access | Times Cited: 14
Opioid-induced analgesia among persons with opioid use disorder receiving methadone or buprenorphine: A systematic review of experimental pain studies
João P. De Aquino, Suprit Parida, Victor J. Avila‐Quintero, et al.
Drug and Alcohol Dependence (2021) Vol. 228, pp. 109097-109097
Open Access | Times Cited: 19
Rapid Overlap Initiation Protocol Using Low Dose Buprenorphine for Opioid Use Disorder Treatment in an Outpatient Setting: A Case Series
Leslie W. Suen, Trevor G. Lee, Michael Silva, et al.
Journal of Addiction Medicine (2022) Vol. 16, Iss. 5, pp. 534-540
Open Access | Times Cited: 12
Inpatient Low-dose Transitions From Full Agonist Opioids Including Methadone Onto Long-acting Depot Buprenorphine: Case Series From a Multicenter Clinical Trial
Nikhil Seval, Johnathan Nunez, Prerana Roth, et al.
Journal of Addiction Medicine (2023) Vol. 17, Iss. 4, pp. e232-e239
Closed Access | Times Cited: 7
Opioids and Opioid Use Disorder in Pregnancy
Aalok R. Sanjanwala, Grace Lim, Elizabeth E. Krans
Obstetrics and Gynecology Clinics of North America (2023) Vol. 50, Iss. 1, pp. 229-240
Closed Access | Times Cited: 7
Challenges with current diagnosis and treatment strategies for precipitated opioid withdrawal in the emergency department and the role of the pharmacist
Melody Glenn, Brian L. Erstad
American Journal of Health-System Pharmacy (2024) Vol. 82, Iss. 2, pp. 60-64
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top